Clinical Trial Update: Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study of Debio-0932 in patients with advanced solid tumors or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphoma

Drugs mentioned

• Debio-0932 (Debio-0932)

Snippet

Sponsor: Debiopharm International SA | Conditions: Cancer, Neoplasms | Phase 1 | Status: COMPLETED